Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | hSTC810 |
Trade Name | |
Synonyms | |
Drug Descriptions |
hSTC810 is an antibody that targets BTN1A1, which potentially inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 5318). |
DrugClasses | Immune Checkpoint Inhibitor 149 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
hSTC810 | hSTC810 | 0 | 1 |
hSTC810 + Paclitaxel | Paclitaxel hSTC810 | 0 | 1 |